Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India

International Journal of Infectious Diseases

Volumn 12, Issue 6, 2008, Pages

  Sundaram, Muthu ^a   Saghayam, Suneeta ^a   Priya, Bhaskar ^a   Venkatesh, Kartik K ^b   Balakrishnan, Pachamuthu ^a   Shankar, Esaki Muthu ^a   Murugavel, Kailapuri G ^a   Solomon, Suniti ^a   Kumarasamy, Nagalingeswaran ^a  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^b BROWN UNIVERSITY   (United States)

Author keywords

Antioxidants; Generic HAART; HIV; India; Oxidative stress

Indexed keywords

ALBUMIN; ANTIOXIDANT; CERULOPLASMIN; EFAVIRENZ; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LAMIVUDINE; STAVUDINE; URIC ACID; ZIDOVUDINE; ZINC;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; TERTIARY HEALTH CARE; VIRUS LOAD;

ADULT; ALBUMINS; ANTI-HIV AGENTS; ANTIOXIDANTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; DRUGS, GENERIC; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIV INFECTIONS; HUMANS; INDIA; LAMIVUDINE; MALE; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; URIC ACID; YOUNG ADULT; ZIDOVUDINE;

EID: 54849435026     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.04.004     Document Type: Article

References (20)

1. Kumarasamy N., Solomon S., Flanigan T.P., Hemalatha R., Thyagarajan S.P., and Mayer K.H. Natural history of human immunodeficiency virus disease in Southern India. Clin Infect Dis 36 (2003) 79-85
2. Young J., Weber R., Rickenbach M., Furrer H., Bernasconi E., Hirschel B., et al. Lipid profiles for antiretroviral-naïve patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antivir Ther 10 (2005) 585-591
3. Friis-Møller N., Weber R., Reiss P., Thiébaut R., Kirk O., d'Arminio Monforte A., et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy: results from the DAD study. AIDS 17 (2003) 1179-1193
4. Jones R., Sawleshwarkar S., Michailidis C., Jackson A., Mandalia S., Stebbing J., et al. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Med 6 (2005) 396-402
5. Orem A., Yandi Y.E., Vanizor B., Cimşit G., Uydu H.A., and Malkoç M. The evaluation of autoantibodies against oxidatively modified low density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet's disease. Clin Biochem 35 (2002) 217-224
6. Greenspan H.C., and Aruoma O. Could oxidative stress initiate programmed cell death in HIV infection? A role from plant derived metabolites having synergistic antioxidant activity. Chem Biol Interact 143 (1994) 145-148
7. Allard J.P., Aghdassi E., Chau J., Salit I., and Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 67 (1998) 143-147
8. Favier A., Sappey C., Leclerc P., Faure P., and Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 91 (1994) 165-180
9. Meydani S.N., and Beharka A.A. Recent developments in vitamin E and the immune response. Nutr Rev 56 (1998) s49-58
10. Randox Radicales Libres. Crumlin, UK: Randox Laboratories Ltd; 1996, p. 1-16.
11. Dworkin B.M., Wormser G.P., Axelrod F., Pierre N., Schwarz E., Schwartz E., et al. Dietary intake in patients with AIDS, patients with AIDS-related complex and serologically positive HIV patients: correlations with nutritional status. J Parenter Enteral Nutr 14 (1990) 605-609
12. Kapembwa M., Bridges C., Joseph A.E., Fleming S.C., Batman P., and Griffin G.E. Ileal and jejunal absorptive function in patients with AIDS and enterococcidial infection. J Infect 21 (1990) 43-53
13. Rock C.L., Jacob R.A., and Bowen P.E. Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E and the carotenoids. J Am Diet Assoc 96 (1996) 693-704
14. Siez H., and Stahl W. Vitamin E and C, β-carotene and other carotenoids as antioxidants. Am J Clin Nutr 62 (1995) 13158-13218
15. Das B.S., Thurnham D.I., and Das D.B. Plasma a-tocopherol, retinol and carotenoids in children with falciparum malaria. Am J Clin Nutr 64 (1996) 94-100
16. Muller F., Svardal A.M., Nordoy I., Berge R.K., Aukrust P., and Froland S.S. Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur J Clin Invest 30 (2000) 905-914
17. Delmas-Beauvieux M.C., Peuchant E., Couchouron A., Constans J., Sergeant C., Simonoff M., et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or b-carotene. Am J Clin Nutr 64 (1996) 101-107
18. Ngondi J.L., Oben J., Forkah D.M., Etame L.H., and Mbanya D. The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. AIDS Res Ther 3 (2006) 19
19. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10 (1991) 2247-2258
20. Walubo A., Smith P.J., and Folb P.I. Oxidative stress during antituberculosis therapy in young and elderly patients. Biomed Environ Sci 8 (1995) 106-110